J&J to consult ethicists on requests for experimental drugs

NEW YORK, May 7 (Reuters) - Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on "compassionate use" requests, in which desperate patients ask drugmakers to let them take an experimental medication, the company announced on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.